FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/063605 [Registered on: 05/03/2024] Trial Registered Prospectively
Last Modified On: 22/04/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   A study to find out ophthalmic manifestations and their risk factors in children with developmental delay 
Scientific Title of Study   An Observational, cross sectional study, to find ophthalmic disorders and their risk factors in children with developmental delay at a tertiary centre in western India.  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr. Gayatri Pawar 
Designation  MBBS, DNB Ophthalmology Resident 
Affiliation  Bhaktivedanta hospital and research institute  
Address  Ophthalmology department,new building, 1st floor, Bhaktivedanta Hospital, Srishti complex, Bhaktivedanta Swami Marg , Mira Road East , Thane

Thane
MAHARASHTRA
401107
India 
Phone  8999586493  
Fax    
Email  gayatripawarrox@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sapna Kini 
Designation  MBBS, DNB OPHTHALMOLOGY , FCRS 
Affiliation  Bhaktivedanta Hospital and research institute  
Address  Ophthalmology department, new building, 1st floor, Bhaktivedanta Hospital, Srishti complex, Bhaktivedanta Swami marg , Mira Road East , Thane

Thane
MAHARASHTRA
401107
India 
Phone  9867600143  
Fax    
Email  sapnakini8@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Gayatri Pawar 
Designation  MBBS, DNB Ophthalmology Resident 
Affiliation  Bhaktivedanta Hospital and research institute  
Address  Ophthalmology department, new building, 1st floor, Bhaktivedanta Hospital, Srishti complex, Bhaktivedanta Swami Marg , Mira Road East , Thane


MAHARASHTRA
401107
India 
Phone  8999586493  
Fax    
Email  gayatripawarrox@gmail.com  
 
Source of Monetary or Material Support  
Bhaktivedanta Hospital and Research institute,Shrishti Complex,Bhaktivedanta Swami Marg, Mira Road(East),Thane-401107  
 
Primary Sponsor  
Name  Bhaktivedanta Hospital and research institute  
Address  Bhaktivedanta Hospital and research institute, Srishti complex, Bhaktivedanta swami marg, Mira Road east Thane 401107 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Gayatri Pawar  Bhaktivedanta Hospital and research institute   Ophthalmology department, Opd no.3, New building Bhaktivedanta hospital Srishti complex, Bhaktivedanta Swami marg Mira Road east 401107
Thane
MAHARASHTRA 
8999586493

gayatripawarrox@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
BhaktiVedanta Hospital Ethics Committee for Biomedical and Health Research   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H53-H54||Visual disturbances and blindness,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil   Nil 
 
Inclusion Criteria  
Age From  1.00 Year(s)
Age To  16.00 Year(s)
Gender  Both 
Details  - Children presenting to Ophthalmic OPD with a history of developmental delay
- Children between 1 year and 16 years of age
 
 
ExclusionCriteria 
Details  - Those not willing to participate in this study
- Children who are very uncooperative for a detailed eye examination 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1. Find out ophthalmic manifestations in children with developmental delay.
2. To find out relative risk of various systemic conditions for corresponding ophthalmic manifestations. 
As this is an cross- sectional study, the outcomes will be assessed at the baseline that is at the time of initial presentation itself.  
 
Secondary Outcome  
Outcome  TimePoints 
1.To find out prevalence of optic atrophy in the examined children.
2.To find out prevalence of periventricular leucomalacia in children with MRI reports & it’s correlation with ophthalmic manifestations. 
As this is an cross sectional study, the study outcomes will be assessed at baseline, that is at the time of initial presentation itself.  
 
Target Sample Size   Total Sample Size="69"
Sample Size from India="69" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   11/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
All the children presenting to the ophthalmology OPD will undergo the following examinations and then will be categorized according to the inclusion criteria for further evaluation. 
Consent will be taken from the parents / guardian for the examination data of their child /ward to be included in the current study.
Examination includes - 
* History taking (Informant will be parents / guardian
Visual acuity (Age-appropriate tools will be used e.g. CSM method, Snellen visual acuity chart, Kay pictures, E chart etc)
Refraction age-appropriate subjective as well as objective refraction
Slit lamp biomicroscopy 
Pupillary reaction
Dilated Fundus examination 
Assessment of Ocular alignment and Ocular Motility 
Sensory evaluation and tests of stereopsis

ENDPOINTS-   
Children with developmental delay may have significant  
Refractive errors 
Nystagmus 
Strabismus 
Anisometropia 
Visual impairment 
Optic Atrophy 
After the detailed recording of data, statistical analysis is to be done. 
Relative risk will be calculated for the ophthalmic disorders like visual impairment, refractive errors and strabismus in relation to clinical conditions like birthweight, prematurity, birth asphyxia, cerebral palsy, epilepsy and genetic syndromes. 





 
Close